OF0176-EYS02-C7, EYS02-MiPS4F7

General

Cell Line

hPSCreg name CABi002-A
Cite as:
CABi002-A (RRID:CVCL_UJ72)
Alternative name(s)
OF0176-EYS02-C7, EYS02-MiPS4F7
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
LUMCi056-A-1
(LUMC0128iCRB01 heterozygote CRISPR corrected isogenic clone 02, iso02LUMC0128iCRB01)
Donor's gene variants:
CRB1, CRB1
Donor diseases:
Retinitis Pigmentosa
ESi077-A
(CABi001-A, PRPF31-MiPS4F3)
Donor's gene variants:
PRPF31, PRPF31
Donor diseases:
Retinitis Pigmentosa
ESi132-A
(PRPF3181-MiPS4F5)
Donor diseases:
Retinitis Pigmentosa
VUi103-A
(hvs543a, MDN 8482277)
Donor diseases:
Retinitis Pigmentosa
VUi103-B
(hvs543b, MDN 8482277)
Donor diseases:
Retinitis Pigmentosa
VUi103-C
(MDN 8482277, hvs543c)
Donor diseases:
Retinitis Pigmentosa
CIRMi508-A
(CW70323)
Donor diseases:
retinitis pigmentosa
CIRMi519-A
(CW70342)
Donor diseases:
retinitis pigmentosa
MUi038-A
(EYS mutation)
Donor diseases:
retinitis pigmentosa
FRIMOi001-A
(RP1_FiPS4F1.6)
Donor diseases:
Retinitis Pigmentosa
LUMCi055-A
(CRB1 patient 117 compound heterozygous 2983G>T p.(Glu995*) c.1892A>G, p.(Tyr631Cys), LUMC0117iCRB01)
Donor's gene variants:
CRB1, CRB1
Donor diseases:
Retinitis Pigmentosa
CIRMi531-A
(CW70356)
Donor diseases:
retinitis pigmentosa
LUMCi056-A
(CRB1 patient 128 compound heterozygous c.2843G>A p.(Cys948Tyr) and c.3122T>C p.(Met1041Thr), LUMC0128iCRB01)
Donor's gene variants:
CRB1, CRB1
Donor diseases:
Retinitis Pigmentosa
CIRMi542-A
(CW70373)
Donor diseases:
retinitis pigmentosa
NUIGi027-A
(RP001C8)
Donor diseases:
Retinitis Pigmentosa
NUIGi028-A
(RP002C12)
Donor diseases:
Retinitis Pigmentosa
NUIGi029-A
(RP003C12)
Donor diseases:
Retinitis Pigmentosa
CIRMi525-A
(CW70348)
Donor diseases:
retinitis pigmentosa
FRIMOi002-A
(RP2_FiPS4F2.2)
Donor diseases:
Retinitis Pigmentosa
FRIMOi005-A
(RP3_FiPS4F11)
Donor diseases:
Retinitis Pigmentosa
BTHBIOi001-A
(BiPSC-HXL-CNGA1)
Donor diseases:
Retinitis Pigmentosa
CUIMCi005-A
(BB#2, BB9068#2)
Donor diseases:
Stargardt Disease
SCTCi014-A
(IPS17-00056)
Donor diseases:
Age-Related Macular Degeneration
SCTCi012-A
(IPS19-00027)
Donor diseases:
age-related macular degeneration
SCTCi013-A
(IPS19-00053)
Donor diseases:
age-related macular degeneration
ESi158-A
(STGD73-MiPS4F8)
Donor diseases:
Stargardt Disease
FJMAi001-A
Donor's gene variants:
FBN1
Donor diseases:
Marfan Syndrome
SCTCi016-A
(IPS18-00092)
Donor diseases:
Leber Congenital Amaurosis
CABi003-A
(DH05, AMDdh05-MiPS4F16)
Donor diseases:
Age-Related Macular Degeneration
SCTCi011-A
(IPS18-00072)
Donor diseases:
age-related macular degeneration
SCTCi015-A
(IPS19-00051)
Donor diseases:
Age-Related Macular Degeneration
KSCBi011-A
(DKHi090-A, DKH090i-A)
Donor diseases:
Leber Congenital Amaurosis
ESi157-A
(STGD90-MiPS4F10)
Donor diseases:
Stargardt Disease
JTUi003-A
Donor diseases:
otosclerosis
BIOi003-A
(LYN-C1-P6)
Donor's gene variants:
ABCA4, ABCA4
Donor diseases:
Hereditary Retinal Dystrophy
SCVIi150-A
(GSB-L159)
Donor diseases:
Marfan Syndrome
SCVIi151-A
(GSB-L2728)
Donor diseases:
Marfan Syndrome
AAKIPSi001-A
Donor diseases:
Aniridia
AAKIPSi002-A
Donor diseases:
Aniridia
Last update 30th March 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator CABIMER (Andalusian Molecular Biology and Regenerative Medicine Centre) (CAB)

External Databases

Cellosaurus CVCL_UJ72
BioSamples SAMEA8268542
Wikidata Q93441237

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Retinitis Pigmentosa

External Databases (Donor)

BioSamples SAMEA8268543

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Comité Coordinador de Ética de a Investigación Biomédica de Andalucía
Approval number PR-01-2015
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Comité Coordinador de Ética de a Investigación Biomédica de Andalucía
Approval number PR-01-2015
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC
Source cell origin
The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.
Synonyms
  • ARM
  • Arm
  • Brachium
  • Upper Arm
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ 1

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
SOX2
Yes
SSEA-3
Yes
TRA 1-81
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
alpha feto protein
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
Actin Smooth Muscle
Unknown
Morphology
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
TUBB3
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46 XY
Passage number: 8

Other Genotyping (Cell Line)